Business

Latest News

stem cells and donor mobilization | Image credit: sola_sola - stock.adobe.com
Ten Years of Data Support Safety of Biosimilar Filgrastim for Donor Mobilization

August 22nd 2025

A 10-year prospective follow-up of 244 healthy stem cell donors found no new safety concerns with Sandoz’s filgrastim biosimilar, reinforcing its long-term safety for donor mobilization.

america health and biosimilars | Image credit: MohamadFaizal - stock.adobe.com
Litigation, Launch, and Lower Costs: 3 Big Moves in the US Biosimilar Space

August 19th 2025

UK health | Image credit: millaf - stock.adobe.com`
Low Prices Fail to Boost Insulin Biosimilar Uptake in the UK

August 11th 2025

medicare price negotiations and biosimilar development  | Image credit: japhoto - stock.adobe.com
Medicare Price Negotiations Will Slow Biosimilar Momentum, Widening Market Gap

July 16th 2025

biosimilar development for biologics coming off patent is limited | Image credit: FUTURESEND - stock.adobe.com
White Paper Offers Tips for Sustaining Biosimilar Progress, Avoiding a Market Void

July 15th 2025

Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CFB podcast banner
CfB podcast banner
CFB podcast banner
CfB podcast banner

More News

© 2025 MJH Life Sciences

All rights reserved.